The Effect of Neurophysiological Facilitation Techniques on Health Parameters in Early Stages After Open Heart Surgery

Официальное название

The Effect of Neurophysiological Facilitation Techniques on Pulmonary Function, Respiratory Muscle Strength and Functional Capacity in The Early Stage After Open Heart Surgery

Обзор

In this study, researchers aimed to investigate effects of neurophysiological facilitation on functional capacity and respiratory parameters of patients who underwent open heart surgery. Do neurophysiological facilitation techniques improve individuals' respiratory parameters more than phase 1 cardiac rehabilitation? Do neurophysiological facilitation techniques improve individuals' functional capacity more than phase 1 cardiac rehabilitation? Researchers will apply phase 1 cardiac rehabilitation to both groups to see the effectiveness of neurophysiological facilitation techniques.

Подробное описание

In this study, researchers aimed to investigate effects of neurophysiological facilitation on functional capacity and respiratory parameters of patients who underwent open heart surgery.

The study was performed on 32 patients who underwent open heart surgery. Patients divided into two groups which study group (n=18) and control group (n=14).

Range of motion, breathing and mobilization exercises within the scope of phase 1 cardiac rehabilitation program were applied to the control group; in addition to the phase 1 cardiac rehabilitation program, neurophysiological facilitation techniques (perioral stimulation, intercostal tension, anterior basal lift, vertebral pressure, moderate manual pressure and abdominal co-contraction) were applied to the study group.

Sociodemographic features and disease-specific findings were recorded on the first postoperative day .

Vital signs, functional capacity, pulmonary function, fatigue and dyspnea of every patient were recorded before and after each treatment on the first four postoperative days.

Functional capacity was evaluated using Timed Up and Go (TUG) test and 2-Minutes Walking test (2MWT). Pulmonary function was examined using a peak flow meter and respiratory muscle strength was measured using an intraoral pressure measurement device. In addition, fatigue and dyspnea perception was measured using Modified Borg Scale.

Before the first day treatment and after the last day treatment of the four-day treatment, patients' fatigue severity were assessed with using Fatigue Severity Scale (FSS), anxiety and depression level with using Hospital Anxiety Depression Scale (HADS), fear of movement with using TAMPA Kinesiophobia Scale and life quality with using the Minnesota Heart Failure Questionnaire.

Before each treatment chest circumference measurements were taken, and the perceived pain severity was recorded using Visual Analog Scale (VAS).

Вмешательства

• Процедура Phase 1 cardiac rehabilitation
  Day 1:Patients were informed about the surgery, positioning and mobilization.Range of motion (ROM), respiratory control, diaphragmatic breathing, pursed lip breathing, thoracal expansion exercises, assisted coughing,forced expiration techniques, which are the components of active breathing techniques cycle (ABTC), were taught.The use of incentive spirometry (IS) was demonstrated.Patients were performed 10 repetitions of IS exercises, and 5 repetitions ABTC and were asked to repeat them every hou
• Процедура Neurophysiological facilitation techniques
  In addition to the phase 1 cardiac rehabilitation program for the group receiving neurophysiological facilitation (NPF) techniques: NPF techniques such as perioral stimulation, intercostal tension, anterior basal lift, vertebral pressure, moderate manual pressure and abdominal co-contraction were applied for ten times for ten seconds. Diaphragm facilitation exercise was performed by inhaling against resistance and holding the breath against resistance for 5 seconds. Unilateral and bilateral u

Первичные конечные точки

• İnspiratory muscle strength [Срок оценки: Before and after treatment on each day of treatment, up to 3 month]
• Expiratory muscle strength [Срок оценки: After and before treatment on each day of treatment, up to 3 month]
• 2 Minute Walk Test [Срок оценки: Before treatment on the first day of treatment and after treatment on the last day of treatment, up to 3 month]
• Time Up and Go (TUG) [Срок оценки: first day of treatment before treatment and last day of treatment after treatment, up to 3 month]
• Vital sign [Срок оценки: Before and after treatment on each day of treatment, up to 3 month]
• Respiratory frequency [Срок оценки: Before and after treatment on each day, up to 3 month]
• Blood pressure [Срок оценки: Before and after treatment on day of treatment, up to 3 month]
• Heart rate [Срок оценки: Before and after treatment on each day of treatment, up to 3 month]
• Life quality [Срок оценки: Before treatment on the first day of treatment and after treatment on the last day of treatment, up to 3 month]
• Depression [Срок оценки: Before treatment on the first day of treatment and after treatment on last day of treatment, up to 3 month]

Критерии участия

Критерии включения

• Having open heart surgery for the first time,
• Being between the ages of 18-75,
• Being fully cooperative

Критерии исключения

• Having facial, sternum and rib fractures,
• Having chronic renal failure,
• Development of cerebrovascular accident,
• Having cognitive dysfunction,
• Development of deep vein thrombosis in the post-operative period,
• Having neuromuscular disease,
• Having an orthopedic disability,
• Intubation time longer than 24 hours,
• Staying in intensive care for more than 48 hours

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение

Рандомизированное

Модель

Параллельные группы

Маскирование

Простое слепое

Основная цель

Лечение

Центры проведения

Turkey (Türkiye) · 1 центр

• Lokman Hekim Akay Hospital — Ankara

Идентификаторы

NCT: NCT06551714 · DogusU

Первоисточники (государственные реестры)

• ClinicalTrials.gov (NIH, США)

Открыть это исследование на ClinicalTrials.gov ↗